Kabra Drugs Ltd. :
Industry Phar BSE Code 524322 Face Value 10.00
Chairman NSE Code KABRADG Market Lot 1
Group Not Applicable ISIN No INE323K01017 Book Closure 30/09/2024
You can view the latest news of the Company.
HeadlinesDate and Time
Kabra Drugs Ltd. - Submission Of Notice Of Extra Ordinary General Meeting Under Regul... 03/12/2025 12:17
Kabra Drugs Ltd. - Appointment Of Secretarial Auditor Of The Company 28/11/2025 18:09
Kabra Drugs Ltd. - Resignation Of Secretarial Auditor Of The Company 28/11/2025 18:07
Kabra Drugs Ltd. - Board Meeting Outcome for Outcome Of Board Meeting Held On 28Th No... 28/11/2025 18:06
Kabra Drugs Ltd. - Board Meeting Intimation for Intimation Of Board Meeting 20/11/2025 13:28
Kabra Drugs Ltd. - Financial Results For The Quarter Ended 30 Th September 2025 Under... 13/11/2025 19:06
Kabra Drugs Ltd. - Board Meeting Outcome for Outcome Of Board Meeting Held On 13 Th N... 13/11/2025 18:55
Kabra Drugs Ltd. - Board Meeting Intimation for Intimation Of Board Meeting 05/11/2025 15:21
Kabra Drugs Ltd. has submitted to BSE the Shareholding Pattern for the Period Ended S... 21/10/2025 20:20
Kabra Drugs Ltd. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations... 13/10/2025 19:39
Kabra Drugs Ltd. - Announcement under Regulation 30 (LODR)-Change in Directorate 09/10/2025 13:00
Kabra Drugs Ltd. - Announcement under Regulation 30 (LODR)-Resignation of Chief Finan... 08/10/2025 18:57
Kabra Drugs Ltd. - Announcement under Regulation 30 (LODR)-Change in Management 08/10/2025 18:56
Kabra Drugs Ltd. - Announcement under Regulation 30 (LODR)-Change in Directorate 08/10/2025 18:53
Kabra Drugs Ltd. - Announcement under Regulation 30 (LODR)-Resignation of Director 08/10/2025 18:46
[Next]
  Company Info
Type first few letters